Trastuzumab and stomatitis Patient Reports February 11, 2012



Trastuzumab Side Effects Report #5464572-0
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Sept 07, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: anaemia, neutropenia, stomatitis. Trastuzumab dosage: 288 MG, UNK. During the same period patient was treated with MYOCET, PACLITAXEL, MUCAINE, SPIRONOLACTONE, CORDALIN, KYTRIL. Patient was hospitalized and became disabled. Patient recovered.

Trastuzumab Side Effects Report #5467222-2
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Sept 10, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, stomatitis. Trastuzumab dosage: 288 MG, UNK. During the same period patient was treated with MYOCET, PACLITAXEL, MUCAINE, SPIRONOLACTONE, CORDALIN, KYTRIL. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #5685063-8
Trastuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 14, 2008. Female patient was diagnosed with breast cancer metastatic, neuralgia, prophylaxis and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: anorexia, blood pressure decreased, gastric ulcer haemorrhage, haemoglobin decreased, heart rate increased, neutrophil count decreased, stomatitis, white blood cell count decreased. Trastuzumab dosage: 198 MG, UNK. During the same period patient was treated with TAXOTERE, LORNOXICAM, DEXAMETHASONE PHOSPHATE, RINDERON, ALCLOXA, ALUMINUM CHLOROHYDRATE. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #6019790-X
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Dec 11, 2008. Female patient was diagnosed with breast cancer What is  breast cancer and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, pain What is  pain, rash maculo-papular, stomatitis. Trastuzumab dosage: 8 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, FERROUS SULPHATE, PROMETHAZINE, PRILOSEC, VICODIN, CYCLOBENZAPRINE. Patient was hospitalized. Patient recovered.


Trastuzumab Side Effects Report #6025593-2
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Dec 18, 2008. Female patient was diagnosed with breast cancer What is  breast cancer and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, pain What is  pain, rash maculo-papular, stomatitis. Trastuzumab dosage: 8 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, FERROUS SULPHATE, PROMETHAZINE, PRILOSEC, VICODIN, CYCLOBENZAPRINE. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #6056077-3
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Jan 13, 2009. Female patient was diagnosed with breast cancer What is  breast cancer and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, pain What is  pain, rash maculo-papular, stomatitis. Trastuzumab dosage: 8 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, FERROUS SULPHATE, PROMETHAZINE, PRILOSEC. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #6130314-9
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Mar 09, 2009. Female patient was diagnosed with breast cancer What is  breast cancer and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, pain What is  pain, rash maculo-papular, stomatitis. Trastuzumab dosage: 8 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, FERROUS SULPHATE, PROMETHAZINE. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Trastuzumab